Back to Newsroom
Back to Newsroom

United States Digital Ovulation Test Kits Market is Estimated to Hit US$ 185 Million, Growing at a CAGR of 9.1% by Forecast End of 2033 | Future Market Insights, Inc.

Wednesday, 14 June 2023 09:20 AM

Future Market Insights, Inc.

NEWARK, DE / ACCESSWIRE / June 14, 2023 / The United States Digital Ovulation Test Kits Market is expected to reach US$ 77.4 million in 2023, with a projected growth to US$ 185.0 million by 2033, exhibiting a significant CAGR of 9.1% during the forecast period.

Key manufacturers in the United States are undertaking various initiatives such as awareness campaigns, medication maintenance, and online education programs to promote women's health and raise awareness about conditions like PCOS and PCOD. The adoption of digital ovulation test kits is on the rise due to their ease of use and accurate results displayed on digital screens.

Discover Our Expert Analysis with Our Sample PDF @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13241

Manufacturers are introducing new features, such as detecting multiple fertility hormones, to meet the demand for advanced digital ovulation tests. However, the availability of alternatives, high prices of digital kits, and occasional product recalls pose challenges to the market's growth. Nonetheless, ongoing product development efforts by companies offering technologically advanced features are reshaping the United States digital ovulation test kit market and driving demand.

The introduction of affordable digital kits by local manufacturers may further boost the market in the future. Branded test kits are projected to be the top-selling product in the digital ovulation test kits market, accounting for over 83% of the revenue by 2031. This is attributed to the increasing availability of branded test kits through e-commerce, which has driven their demand.

The top two players currently cover more than 72% of the market share in the United States Institutional sales, are driven by increasing fertility awareness and the growing demand for ovulation testing in hospitals. These are expected to be the leading distribution channel, generating a revenue of US$ 95.1 million by 2031.

Branded test kits dominate the United States digital ovulation test kits market, holding a market share of nearly 85.20% in 2022. The leading players in the market are actively promoting their branded test kits through various e-commerce platforms, driving their high demand.

Institutional sales, on the other hand, contribute a significant revenue share of over 54.21% in the market. This is primarily due to the widespread availability of digital ovulation test kits in hospital pharmacies and fertility centers, ensuring easy access for consumers and a higher likelihood of finding quality products.

Reach Out to Our Analyst For Further Info @ https://www.futuremarketinsights.com/ask-question/rep-gb-13241

Competitive Landscape:

Swiss Precision Diagnostics GmbH, Church & Dwight Co. Inc., Prestige Consumer Healthcare, Inc., Hilin Life Products., Fairhaven Health LLC, Geratherm Medical AG, Piramal Enterprises Ltd, NecLife, and others are some market participants identified in the global Ovulation Test Kit market.

  • Crown Laboratories, a prominent, fully integrated global skincare company and a Hildred Capital Management LLC portfolio company, and L Catterton, the world's leading consumer-focused private equity firm, announced the acquisition of StriVectin in August 2021. The transaction, subject to regulatory clearances and other standard closing conditions, is scheduled to be completed by mid-September 2021.
  • In June 2021, bioMérieux announced the sale of a detailed diagnostics' REVEAL Rapid AST system in Europe, strengthening the market for rapid testing kits.
  • Through the Real Talk with Conceiving Hood Campaign, actress Jordana Brewster collaborated with Clearblue in April 2021 to raise awareness about the difficulty of conceiving and women's fertility.

Key Companies Profiled:

  • Swiss Precision Diagnostics GmbH
  • Church & Dwight Co., Inc.
  • Gregory Pharmaceutical Holdings, Inc.
  • Sugentech, Inc.
  • iXensor Co. Ltd
  • Samplytics Technologies Private Limited
  • Bio-AMD

Market Segmentation:

By Product:

  • Branded Test Kits
  • Private Label Test Kits

By Distribution Channel:

  • Institutional Sales
  • Hospital Pharmacies
  • Gynaecology Clinics
  • IVF Clinics
  • Maternity Care Centers
  • Retail Sales
  • Retail Pharmacies
  • Drug Stores
  • Hypermarkets & Supermarkets
  • Online Sales

Get a Customized Scope to Match Your Need - Ask our Expert @ https://www.futuremarketinsights.com/customization-available/rep-gb-13241

1. Executive Summary

1.1. USA Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Product Life Cycle Analysis

3.5. Supply Chain Analysis

3.5.1. Supply Side Participants and Their Roles

3.5.1.1. Producers

3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

3.5.1.3. Wholesalers and Distributors

3.5.2. Value Added and Value Created at Node in the Supply Chain

3.5.3. List of Raw Material Suppliers

3.5.4. List of Existing and Potential Buyers

3.6. Investment Feasibility Matrix

3.7. Value Chain Analysis

3.7.1. Profit Margin Analysis

3.7.2. Wholesalers and Distributors

3.7.3. Retailers

3.8. PESTLE and Porter's Analysis

3.9. Regulatory Landscape

3.9.1. By Key Regions

3.9.2. By Key Countries

3.10. Regional Parent Market Outlook

3.11. Production and Consumption Statistics

3.12. Import and Export Statistics

4. Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022

4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022

5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033

5.3.1. Branded Test Kits

5.3.2. Private Label Test Kits

5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022

5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033

6. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel

View the Complete ToC of this Report with figures @ https://www.futuremarketinsights.com/toc/rep-gb-13241

Explore FMI's related ongoing Coverage in Healthcare Market Domain:

HDL Cholesterol Kits Market Size: Sales in the global HDL Cholesterol Kits Market are slated to top US$ 568.1 Million in 2022. Expanding at a healthy 4.8% CAGR, the market size is projected to total US$ 786.2 Million by 2029.

Cryptococcal Antigen Lateral Flow Assay Test Market Share: The global cryptococcal antigen lateral flow assay test market was valued at around US$ 688.19 Million at the end of 2021. The market is projected to register a 3.73% CAGR and top a valuation of US$ 713.85 Million by 2032.

Respiratory Pathogen Testing Kits Market Trends: As per the latest market research conducted by FMI, the global respiratory pathogen testing kits market is expected to record a CAGR of 5.7% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 4,083.1 million. By 2033, the valuation is expected to be worth US$ 7,136.8 million.

Cardiac Biomarker Diagnostic Test Kits Market Growth: The global Cardiac Biomarker Diagnostic Test Kits Market is slated to top US$ 1.8 Bn by the end of 2022, estimates from Future Market Insights (FMI). With the growing prevalence of cardiac diseases, the overall market is projected to expand at 5.1% CAGR over the forecast period, from 2022 to 2028.

Fertility and Pregnancy Rapid Test Kits Market Outlook: Expanding at a CAGR of 4.3%, the global Fertility And Pregnancy Rapid Test Kits Market is projected to increase from an estimated valuation of US$ 1.34 Billion in 2022 to US$ 1.88 Billion by 2030.

About Future Market Insights (FMI):

Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10 years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: [email protected]
Website: https://www.futuremarketinsights.com
LinkedIn | Twitter | Blogs | YouTube

SOURCE: Transparency Market Research inc.

Topic:
Company Update
Back to newsroom
Back to Newsroom
Share by: